Thursday October 29, 2020

Irish pharma firm seeks $65m for cancer drug

17th December, 2014
John Fox, chief executive, Merrion Pharmaceuticals. PIcture: Feargal Ward

Merrion Pharmaceuticals, the publicly quoted Irish pharma company, is seeking to raise $65 million from investors to fund a new breast cancer drug.

The company, which is traded on the small cap market in Dublin, is hoping to raise the money as soon as possible to fund clinical drug trials for a product it believes will drive it into the future.

Merrion is eyeing up either a new equity partner or a partnership deal on the...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

2 Yearly



Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Related Stories

The way we did business a few months ago may never return – so the opportunity is to make changes that will both aid recovery and set us up well for our new futures

Tom Maguire | 5 months ago

What’s coming up today and what you might have missed

Hannah O’Brien | 10 months ago